XML 58 R41.htm IDEA: XBRL DOCUMENT
v3.25.1

Share Based Awards (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2025
Share-Based Payment Arrangement [Abstract] |
Schedule of Assumptions Used to Calculate the Fair Value of Options Granted | The range of assumptions used to calculate the fair value of options granted during the three months ended March 31, 2025 was: Schedule of Assumptions Used to Calculate the Fair Value of Options Granted
Exercise Price |  |  | $ 8.56 – 8.56 |
Stock price on date of grant |  |  | 8.46 – 8.46 |
Risk-free interest rate |  |  | 4.44 – 4.44 | %
Dividend yield |  |  | — |
Expected term (years) |  |  | 5.97 – 5.97 |
Volatility |  |  | 191.15 – 191.15 | %
Schedule of Options Activity | A summary of options activity under the Plan since December 31, 2024 was: Schedule of Options Activity
|  | Shares |  |  | Weighted- Average Exercise Price |  |  | Weighted- Average Remaining Contractual Term |  |  | Aggregate Intrinsic Value |
Outstanding as of December 31, 2024 |  |  | 5,645,325 |  |  |  | 1.54 |  |  |  | 7.90 |  |  |  | 59,779,836 |
Granted |  |  | 402,500 |  |  |  | 8.56 |  |  |  |  |  |  |  |  |
Exercised |  |  | (908,503 | ) |  |  | 1.28 |  |  |  |  |  |  |  |  |
Forfeited or expired |  |  | (127,502 | ) |  |  | 1.73 |  |  |  |  |  |  |  |  |
Outstanding as of March 31, 2025 |  |  | 5,011,820 |  |  |  | 2.06 |  |  |  | 1.99 |  |  |  | 20,221,803 |
Exercisable as of March 31, 2025 |  |  | 1,633,529 |  |  | $ | 1.47 |  |  |  | 1.35 |  |  | $ | 7,200,542 |
Schedule of Restricted Stock Activity | A summary of restricted stock activity under the Plan since December 31, 2024 was: Schedule of Restricted Stock Activity
|  | Shares |  |  | Weighted Average Grant-Date Fair Value Per Share |
Unvested and outstanding as of December 31, 2024 |  |  | 1,544,027 |  |  | $ | 3.84 |
Granted |  |  | 50,000 |  |  |  | 4.94 |
Vested |  |  | — |  |  |  | — |
Forfeited |  |  | (321,428 | ) |  |  | 0.89 |
Unvested and outstanding as of March 31, 2025 |  |  | 1,272,599 |  |  | $ | 4.64 |
Schedule of Stock Compensation Expense by Functional Operating Expense | Stock compensation expense for the three months ended March 31 by functional operating expense was: Schedule of Stock Compensation Expense by Functional Operating Expense
|  | 2025 |  |  | 2024 |
Research and development |  | $ | 174,460 |  |  | $ | 115,477 |
Sales and marketing |  |  | 862,983 |  |  |  | 85,205 |
General and administrative |  |  | 561,529 |  |  |  | 604,952 |
Total |  | $ | 1,598,972 |  |  | $ | 805,634 |

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested restricted stock shares. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Subparagraph (c) -Paragraph 2 -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration